Dr. Adam Christopher Aubuchon
M.D. | Neurology | 15+ years Exp
1814 Westchester Dr Ste 401, High Point
North Carolina, 27262-7369
336-802-2080 Maps & DirectionsDr. Adam Christopher Aubuchon is a High Point, North Carolina based neurologist with 15 years of experience in Neurology. He completed his graduation in 2011. He is also affiliated with hospitals like and . He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Adam Christopher Aubuchon is 2018-01973 for Neurology in North Carolina. His current practice location is 1814 Westchester Dr Ste 401, High Point. Patients can reach him at 336-802-2080. Dr. Adam Christopher Aubuchon is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1336431451.
Dr. Adam Christopher Aubuchon specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Adam Christopher Aubuchon speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
| Name: | Dr. Adam Christopher Aubuchon |
| Specialization: | Neurology |
| Gender: | Male |
| Credentials: | M.D. |
| Experience: | 15+ years |
| Medical School Attended: | Other |
| Graduation Year: | 2011 |
| Accepts Medicare Assignment: | Yes |
| Practice Address: | 1814 Westchester Dr Ste 401, High Point, North Carolina, 27262-7369 |
| Phone: | 336-802-2080 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 0446499354 |
| Enrollment ID: | I20180814001409 |
| NPI Number: | 1336431451 |
| NPI Enumeration Date: | 08 May, 2011 |
| NPI Last Update On: | 15 May, 2020 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Adam Christopher Aubuchon are as mentioned below.
| License Number | Specialization | State | Status | |
| 2018-01973 | Neurology | North Carolina | Primary | |
| 9674098-1205 | Neurology | Utah | Secondary | |
| Student in an Organized Health Care Education/Training Program | | Secondary | |
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
| Hospital Name (CCN) | State | Hospital Type |
| (340047) | Winston-salem, NC | Acute Care Hospital |
| (340187) | Mocksville, NC | Acute Care Hospital |
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Adam Christopher Aubuchon is associated with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| Wake Forest Health Network Llc (4183538895) | 264 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Dr. Adam Christopher Aubuchon Medical Center Blvd, Winston Salem, North Carolina |
| Zip: | 27157-0001 |
| Phone Number: | 336-716-1331 |
| Fax Number: | 336-716-3202 |
Patients can reach Dr. Adam Christopher Aubuchon at
1814 Westchester Dr Ste 401, High Point, North Carolina or can
call to book an appointment on 336-802-2080.
Comments/ Reviews:
Read all the reviews posted for Dr. Adam Christopher Aubuchon below. You may also share your own experience with Dr. Adam Christopher Aubuchon. Your feedback can help others make better decisions.
**
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.